Novacyt shares jump 32% on launch of coronavirus test
Source: CNBC
PUBLISHED FRI, JAN 31 20204:16 AM EST
Elliot Smith
KEY POINTS• Novacyt has launched a diagnostic test for the new strain of coronavirus, which originated in Wuhan and has spread worldwide, leading the World Health Organization (WHO) to declare a global health emergency.
Novacyt stock soared 32% on Friday morning after the French cellular diagnostics company announced the launch of a new test for the coronavirus.
The test has been developed as a direct response to the recent outbreak of the new strain of coronavirus, which originated in the Chinese city of Wuhan and has now spread worldwide, leading the World Health Organization (WHO) to declare a global health emergency.
Read more: https://www.cnbc.com/2020/01/31/nova...irus-test.html
(Note- shares now trading up 81% today, at 0.45 cents a share, on the Paris exchange. )
STOCK SYMBOLS:
Paris Exchange: Novacyt S.A. (ALNOV.PA)
London Exchange: Novacyt S.A. (NCYT.L)
Bookmarks